Lifeline Scientific Inc - Shs Reg-S

LSE:LSI (USA)   Shs Reg-S
£ 1.37 (0%) Dec 19
6.57
P/B:
2.29
Market Cap:
£ 26.67M ($ 33.98M)
Enterprise V:
£ 26.67M ($ 33.98M)
Volume:
-
Avg Vol (2M):
-
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Lifeline Scientific Inc ( LSE:LSI ) from 1990 to May 31 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Lifeline Scientific stock (LSE:LSI) PE ratio as of May 31 2024 is 6.57. More Details

Lifeline Scientific Inc (LSE:LSI) PE Ratio (TTM) Chart

To

Lifeline Scientific Inc (LSE:LSI) PE Ratio (TTM) Historical Data

Total 0
  • 1
Lifeline Scientific PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Lifeline Scientific Inc (LSE:LSI) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Lifeline Scientific Inc
NAICS : 334510 SIC : 3845
ISIN : USU529641008

Share Class Description:

LSE:LSI: Shs Reg-S
Description
Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.